Daneshmand, S., Canter, D., Krupski, T. L., Shoskes, D. A., Armandi, D., Shore, N. D. (2025). ABLE-41, a real-world evidence study for bladder cancer patients treated with nadofaragene firadenovec: Baseline patient characteristics and demographics.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16608